NAMSNewAmsterdam Pharma Company N.V.
+2.8% today · −41.7% over a year
1/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 4% of the instruments we score
Trend, Stability: among the weakest; priced higher than most peers. No dividend.
NewAmsterdam Pharma Company N.V. (NAMS) valuation against sector peers: P/B 4.0, free-cash-flow yield −5.7%, P/S 353.7.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | NAMS | Sector median | vs median |
|---|---|---|---|
| P/E | — | 22.4 · n=28 | — |
| P/B | 4.0 | 3.6 · n=45 | 12% above |
| P/S | 353.7 | 4.5 · n=40 | 7,823% above |
| EV/EBIT | — | 20.8 · n=28 | — |
| Free-cash-flow yield | −5.7% | 3.5% · n=41 | 265% below |
| Dividend yield | 0.00% | 0.12% · n=100 | 100% below |
| Return on equity | −36.8% | 6.8% · n=56 | 644% below |
| Return on invested capital | −115.9% | 7.0% · n=47 | 1,749% below |
| Gross margin | — | 70.2% · n=39 | — |
| Net debt / EBITDA | — | 1.39 · n=26 | — |
Value factor: 15 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| NVSNovartis AG | 21.3 | 6.5 | 17.9 | 5.9% | 2.5% | 9/10 |
|---|---|---|---|---|---|---|
| NOVNNovartis AG | 21.2 | 6.4 | 17.8 | 5.9% | 2.9% | 10/10 |
| AZNAstraZeneca plc | 25.7 | 5.4 | 20.9 | 4.5% | 1.9% | 6/10 |
| AZNAstraZeneca PLC | 25.7 | 5.4 | 20.9 | 4.5% | 1.3% | 6/10 |
| NVONovo Nordisk A/S | 11.2 | 5.9 | 9.8 | 5.2% | 4.8% | 7/10 |
| GSKGSK plc | 13.8 | 4.8 | 11.3 | 8.1% | 3.7% | 10/10 |
| SNYSanofi | 11.8 | 1.3 | 16.3 | 7.8% | 5.0% | 7/10 |
| SANSanofi SA | 11.8 | 1.3 | 16.2 | 7.8% | 5.5% | 8/10 |
| TEVATeva Pharmaceutical Industries Limited | 66.0 | 6.0 | 37.2 | 2.9% | 0.0% | 6/10 |
| ALCAlcon | 34.7 | 1.5 | 27.3 | 5.1% | 0.4% | 4/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Jun 2026 · filed 05 Aug 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.